“Permissive anemia”

Journal of Cardiac Surgery

Volumn 34, Issue 11, 2019, Pages 1147-1149

  Calcaterra, Domenico ^a   Ricci, Marco ^b   Shander, Aryeh ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ANAEROBIC METABOLISM; ANEMIA; AUTOREGULATION; BLEEDING; BLOOD CONSERVATION; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; EDITORIAL; ERYTHROCYTE TRANSFUSION; FOLLOW UP; GROUPS BY AGE; HEART INFARCTION; HEART OUTPUT; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INTRAOPERATIVE PERIOD; MEAN ARTERIAL PRESSURE; MORTALITY; OXYGEN CONSUMPTION; OXYGENATION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; TREATMENT OUTCOME; VASOCONSTRICTION; ADVERSE EVENT; AGED; COMPLICATION; FEMALE; HEART SURGERY; MALE; OPERATIVE BLOOD LOSS; POSTOPERATIVE HEMORRHAGE; PROCEDURES;

AGED; ANEMIA; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; POSTOPERATIVE HEMORRHAGE;

EID: 85070962909     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/jocs.14221     Document Type: Editorial

References (13)

1. Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med. 2017;377(22):2133-2144. https://doi.org/10.1056/NEJMoa1711818
2. Mazer CD, Whitlock RP, Fergusson DA, et al. Six-month outcomes after restrictive or liberal transfusion for cardiac surgery. N Engl J Med. 2018;379(13):1224-1233. https://doi.org/10.1056/NEJMoa1808561 Epub 2018 Aug 26.
3. Calcaterra D, Renfro LA, Shander A. Navigating the fine line between the bad and worse: the issue is not the number, and the message is not “All or Nothing”. J Cardiothorac Vasc Anesth. 2016;30(5):1159-1162.
4. Moskowitz DM, McCullough JN, Shander A, et al. The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective? Ann Thorac Surg. 2010;90:451-458.
5. Hajjar LA, Vincent JL, Galas FRBG, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304:1559-1567.
6. Ferraris VA, Martin JP. Is limiting transfusion safe? The devil is in the details. J Thorac Cardiovasc Surg. 2015;150:1032-1034.
7. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;372(11):997-1008.
8. Shehata N, Mistry N, da Costa BR, et al. Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. Eur Heart J. 2019;40(13):1081-1088.
9. Wolff CB. Advances in experimental medicine and biology. Adv Exp Med Biol. 2007;599:169-182.
10. Hong T, Shander A, Agarwal S, Castresana M. Management of a Jehovah's witness patient with sepsis and profuse bleeding after emergency coronary artery bypass graft surgery: rethinking the critical threshold of oxygen delivery. A Case Rep. 2015;4:127-131.
11. Slight RD, Lux D, Nzewi OC, McClelland DBL, Mankad PS. Oxygen delivery and hemoglobin concentration in cardiac surgery: when do we have enough? Artif Organs. 2008;32:949-955.
12. Murphy GS, Hessel EA 2nd, Groom RC. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg. 2009;108(5):1394-1417.
13. Ranucci M, Romitti F, Isgrò G, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg. 2005;80(6):2213-2220.